We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Must Tackle Anti-Competitive Drug Rebate Practices

Law360 (May 17, 2019, 3:22 PM EDT) -- Pharmaceutical manufacturers have implemented a strategy to block and delay entry of new innovative drugs from the market through a contracting practice that creates what is known as a “rebate wall”...
To view the full article, register now.